Leigha Senter, MS, LGC, discusses ongoing biomarker research efforts in ovarian cancer.
Leigha Senter, MS, LGC
Advertisement
Articles by Leigha Senter, MS, LGC
Leigha Senter, MS, LGC, discusses optimal testing methods in ovarian cancer.
Leigha Senter, MS, LGC, discusses the development of genetic testing in ovarian cancer.
Leigha Senter, MS, LGC, discusses the implications of identifying genes beyond BRCA1/2 in women with ovarian cancer.
Advertisement
Latest Updated Articles
Potential of Genetic Testing Beyond BRCA1/2 in Ovarian CancerNovember 8th 2019
The Development of Genetic Testing in Ovarian CancerJanuary 6th 2020
Optimal Testing Methods in Ovarian CancerFebruary 12th 2020
Biomarker Research in Ovarian CancerFebruary 13th 2020
Advertisement
Advertisement
Trending on OncLive
1
HERIZON-GEA-01 PD-L1 Subgroup Data Support Zanidatamab Combo as a New Frontline SOC in HER2+ GEA
2
Antibody-Drug Conjugates in Lung Cancer: The Tip of the Iceberg
3
Retrospective Data Show Zanubrutinib May Less AFib Burden in Real-World CLL
4
Selinexor Plus Ruxolitinib Yields Superior Spleen Responses, OS Signal in JAK Inhibitor–Naïve Myelofibrosis
5